We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

PerkinElmer Enhances Mass Spectrometry Product Range and Expertise

By LabMedica International staff writers
Posted on 11 May 2009
PerkinElmer (Waltham, MA, USA) has enhanced its mass spectrometry (MS) portfolio and expertise with the acquisition of Analytica (Branford, CT, USA). The acquisition is an integral part of PerkinElmer's commitment to enlarge its human and environmental health portfolio. With the completion of this acquisition, PerkinElmer will gain significant insight and intellectual property in the field of MS and ion source technology. Terms of the acquisition were not disclosed.

For human health applications, mass spectrometry provides an extremely detailed profile of medically relevant materials in molecular diagnostics and drug discovery. Other areas of applications include pharmaceutical and nutraceutical materials analysis, forensics, and food safety.

PerkinElmer will integrate Analytica's current manufacturing operations into its Shelton, CT (USA) facility, while utilizing Analytica's existing Branford facility for R&D projects. Craig Whitehouse will become an employee of PerkinElmer and oversee PerkinElmer's MS R&D operations.

"Mass spectrometry has proven to be an essential tool in many fields and will continue to be of critical importance. Bringing Analytica's technology and team of highly innovative experts in-house will dramatically increase our capabilities in this area," said Richard Begley, Ph.D., president, analytical sciences, PerkinElmer.

Related Links:

PerkinElmer



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automatic CLIA Analyzer
Shine i6000
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
11 May 2009  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
11 May 2009  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
11 May 2009  |   BioResearch